Lidocain

Lidocaine, the active ingredient in Lidocain, is a local anesthetic presented as a topical preparation for cutaneous use. It provides surface numbness and pain relief for minor skin procedures and irritations. GNH USA supplies Lidocain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is employed to achieve local anesthesia on the skin and mucous membranes, reducing pain during minor procedures and irritative conditions.

- Minor surgical procedures: provides surface numbness to facilitate incision or suturing. - Dermatologic irritations: relieves pain and itching from insect bites, sunburn, or minor burns. - Diagnostic procedures: numbs skin before needle insertion or biopsy. - Dental procedures: reduces discomfort during superficial oral mucosa work.

Lidocaine may cause a range of adverse reactions following topical application.

Common Side Effects: - Localized burning or stinging at the application site. - Redness or mild erythema. - Pruritus or itching. - Mild swelling or edema. - Transient numbness lasting longer than expected.

Serious or Rare Side Effects: - Systemic toxicity presenting as dizziness, tinnitus, or visual disturbances. - Cardiac arrhythmias or hypotension in cases of excessive absorption. - Severe allergic reactions including rash, angioedema, or anaphylaxis. - Methemoglobinemia, especially with large surface area use. - Seizures or convulsions in rare overdose scenarios.

When using lidocaine topical products, consider the following safety measures.

- Dosage limitation: adhere to recommended surface area and frequency to avoid systemic absorption. - Patient assessment: evaluate for known hypersensitivity to amide‑type local anesthetics. - Concomitant conditions: use cautiously in patients with cardiac conduction disorders or liver impairment. - Pediatric use: limit application area and monitor closely in children. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lidocaine may interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): additive cardiotoxic effects. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase systemic lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., propranolol): may enhance bradycardia. - Other local anesthetics: cumulative toxicity risk. - Central nervous system depressants (e.g., benzodiazepines): may potentiate CNS depression. - Alcohol: can increase systemic absorption and toxicity.